Journal articles
Mylonakis E, 2022, 'Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 A Randomized Controlled Trial', Annals of Internal Medicine, 175, pp. 1266 - 1274, http://dx.doi.org/10.7326/M22-1503
Hung RKY; Rosenberg KL; David V; Binns-Roemer E; Booth JW; Hilton R; Fox J; Burns F; Ustianowski A; Cosgrove C; Hamzah L; Burns JE; Clarke A; Chadwick D; Price DA; Kegg S; Campbell L; Bramham K; Sabin CA; Post FA; Winkler CA; Waters A; Hand J; Clarke C; Murphy S; Murphy M; Campbell M; Richardson C; Knott A; Weir G; Cleig R; Soviarova H; Barbour L; Adams T; Kennard V; Trevitt V; Jones R; Levy J; Schoolmeester A; Duro S; Rabuya M; Jordan D; Solano T; Uzu H; Williams K; Lwanga J; Reid-Amoruso LE; Gamlen H; Stocker RJ; Ryan F; Mahiouz K; Cheetham T; Williams C; Nori A; Thomas C; Venkateshwaran S; Doctor J; Berlanga A; Santana-Suarez B; McQueen L; Bhagwandin P; Barbini B; Wandolo E; Appleby T; Driver L; Parr S; Deng H; Barber J; Crowe A; Taylor C; Poulton M; Boateng V; Klein MP; O'Brien C; Ohene-Adomako S; Buckingham C; Trotman D; Quinn K; Flanagan K; Sullivan V; Middleditch H; Samuel I; Hamlyn E; McDonald C; Canoso A; Agbasi E; Liskova M; Barber S; Samarawickrama A; Ottaway Z; Norcross C; Oliveira A; Minton J; Lamont G; Cross R; Saiyad G; Ahmed S; Ashworth R; Window N; Murira J, 2022, 'GSTM1 Copy Number and Kidney Disease in People With HIV', Kidney International Reports, 7, pp. 1901 - 1904, http://dx.doi.org/10.1016/j.ekir.2022.05.003
Mullender C; da Costa KAS; Alrubayyi A; Pett SL; Peppa D, 2022, 'SARS-CoV-2 immunity and vaccine strategies in people with HIV', Oxford Open Immunology, 3, pp. iqac005, http://dx.doi.org/10.1093/oxfimm/iqac005
Self WH; Sandkovsky U; Reilly CS; Vock DM; Gottlieb RL; Mack M; Golden K; Dishner E; Vekstein A; Ko ER; Der T; Franzone J; Almasri E; Fayed M; Filbin MR; Hibbert KA; Rice TW; Casey JD; Hayanga JA; Badhwar V; Leshnower BG; Sharifpour M; Knowlton KU; Peltan ID; Bakowska E; Kowalska J; Bowdish ME; Sturek JM; Rogers AJ; Files DC; Mosier JM; Gong MN; Douin DJ; Hite RD; Trautner BW; Jain MK; Gardner EM; Khan A; Jensen JU; Matthay MA; Ginde AA; Brown SM; Higgs ES; Pett S; Weintrob AC; Chang CC; Murrary DD; Günthard HF; Moquete E; Grandits G; Engen N; Grund B; Sharma S; Cao H; Gupta R; Osei S; Margolis D; Zhu Q; Polizzotto MN; Babiker AG; Davey VJ; Kan V; Thompson BT; Gelijns AC; Neaton JD; Lane HC; Jundgren JD; Tierney J; Barrett K; Herpin BR; Smolskis MC; Voge SE; McNay LA; Cahill K; Crew P; Kirchoff M; Sardana R; Raim SS; Chiu J; Hensley L; Lorenzo J; Mock R; Shaw-Saliba K; Zuckerman J; Adam SJ; Currier J; Read S; Hughes E; Amos L; Carlsen A; Carter A; Davis B; Denning E; DuChene A; Harrison M; Kaiser P; Koopmeiners J; Meger S; Murray T; Quan K, 2022, 'Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial', Lancet Infectious Diseases, 22, pp. 622 - 635, http://dx.doi.org/10.1016/S1473-3099(21)00751-9
Hung RKY; Binns-Roemer E; Booth JW; Hilton R; Harber M; Santana-Suarez B; Campbell L; Fox J; Ustianowski A; Cosgrove C; Burns JE; Clarke A; Price DA; Chadwick D; Onyango D; Hamzah L; Bramham K; Sabin CA; Winkler CA; Post FA; Booth J; Waters A; Hand J; Clarke C; Murphy S; Murphy M; Campbell M; Richardson C; Knott A; Weir G; Cleig R; Soviarova H; Barbour L; Adams T; Kennard V; Trevitt V; Jones R; Levy J; Schoolmeester A; Duro S; Rabuya M; Jordan D; Solano T; Uzu H; Williams K; Lwanga J; Reid-Amoruso LE; Gamlen H; Stocker RJ; Ryan F; Mahiouz K; Cheetham T; Williams C; Nori A; Thomas C; Venkateshwaran S; Doctor J; Berlanga A; McQueen L; Bhagwandin P; Barbini B; Wandolo E; Appleby T; Driver L; Parr S; Deng H; Barber J; Crowe A; Taylor C; Poulton M; Boateng V; Klein MP; O'Brien C; Ohene-Adomako S; Buckingham C; Trotman D; Quinn K; Flanagan K; Sullivan V; Middleditch H; Samuel I; Hamlyn E; McDonald C; Canoso A; Agbasi E; Liskova M; Barber S; Samarawickrama A; Ottaway Z; Norcross C; Oliveira A; Minton J; Lamont G; Cross R; Saiyad G; Ahmed S; Ashworth R; Window N; Murira J, 2022, 'Genetic Variants of APOL1 Are Major Determinants of Kidney Failure in People of African Ancestry With HIV', Kidney International Reports, 7, pp. 786 - 796, http://dx.doi.org/10.1016/j.ekir.2022.01.1054
Burns JE; Stirrup O; Waters L; Dunn D; Gilson R; Pett SL, 2022, 'No overall impact on rate of weight gain with integrase inhibitor-containing regimens in antiretroviral-naïve adults', HIV Medicine, 23, pp. 294 - 300, http://dx.doi.org/10.1111/hiv.13186
Hung RKY; Binns-Roemer E; Booth JW; Hilton R; Fox J; Burns F; Harber M; Ustianowski A; Hamzah L; Burns JE; Clarke A; Price DA; Kegg S; Onyango D; Santana-Suarez B; Campbell L; Bramham K; Sharpe CC; Sabin CA; Winkler CA; Post FA; Booth J; Waters A; Hand J; Clarke C; Murphy S; Murphy M; Campbell M; Richardson C; Knott A; Weir G; Cleig R; Soviarova H; Barbour L; Adams T; Kennard V; Trevitt V; Jones R; Levy J; Schoolmeester A; Duro S; Rabuya M; Jordan D; Solano T; Uzu H; Williams K; Lwanga J; Reid-Amoruso LE; Gamlen H; Stocker RJ; Ryan F; Mahiouz K; Cheetham T; Williams C; Nori A; Thomas C; Venkateshwaran S; Doctor J; Berlanga A; McQueen L; Bhagwandin P; Barbini B; Wandolo E; Appleby T; Driver L; Parr S; Deng H; Barber J; Crowe A; Taylor C; Poulton M; Boateng V; Klein MP; O'Brien C; Ohene-Adomako S; Buckingham C; Trotman D; Quinn K; Flanagan K; Sullivan V; Middleditch H; Samuel I; Hamlyn E; McDonald C; Canoso A; Agbasi E; Liskova M; Barber S; Samarawickrama A; Ottaway Z; Norcross C; Oliveira A; Minton J; Lamont G; Cross R; Saiyad G; Ahmed S; Ashworth R; Window N, 2022, 'Sickle Cell Trait and Kidney Disease in People of African Ancestry With HIV', Kidney International Reports, 7, pp. 465 - 473, http://dx.doi.org/10.1016/j.ekir.2021.12.007
Polizzotto M; Nordwall J; Babiker AG; Phillips A; Vock DM; Eriobu N; Khwaghe V; Paredes R; Mateu L; Ramachandruni S; Narang R; Jain MK; Lazarte SM; Baker JV; Frosch AEP; Poulakou G; Syrigos KN; Arnoczy GS; McBride NA; Robinson PA; Sarafian F; Bhagani S; Taha HS; Benfield T; Liu STH; Antoniadou A; Jensen JUS; Kalomenidis I; Susilo A; Hariadi P; Jensen TO; Morales-Rull JL; Helleberg M; Meegada S; Johansen IS; Canario D; Fernández-Cruz E; Metallidis S; Shah A; Sakurai A; Koulouris N; Trotman R; Weintrob AC; Podlekareva D; Hadi U; Lloyd KM; Røge BT; Saito S; Sweerus K; Malin JJ; Lübbert C; Muñoz J; Cummings MJ; Losso MH; Turner D; Shaw-Saliba K; Highbarger H; Lallemand P; Rehman T; Dewar R; Gerry N; Arlinda D; Chang CC; Grund B; Holbrook M; Holley HP; Hudson F; McNay LA; Murray DD; Pett S; Shaughnessy M; Smolskis MC; Touloumi G; Wright M; Doyle MK; Popik S; Hall C; Ramanathan R; Cao H; Mondou E; Willis T; Thakuria JV; Yel L; Higgs E; Kan VL; Lundgren JD; Neaton JD; Lane HC; Amos L; Carlsen A; Carter A; Davis B; Denning E; DuChene A; Engen N; Grandits G; Harrison M; Kaiser P; Meger S; Murray T, 2022, 'Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial', Lancet, 399, pp. 530 - 540, http://dx.doi.org/10.1016/S0140-6736(22)00101-5
Murray DD; Babiker AG; Baker JV; Barkauskas CE; Brown SM; Chang CC; Davey VJ; Gelijns AC; Ginde AA; Grund B; Higgs E; Hudson F; Kan VL; Lane HC; Murray TA; Paredes R; Parmar MKB; Pett S; Phillips AN; Polizzotto MN; Reilly C; Sandkovsky U; Sharma S; Teitelbaum M; Thompson BT; Young BE; Neaton JD; Lundgren JD, 2022, 'Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)', Clinical Trials, 19, pp. 52 - 61, http://dx.doi.org/10.1177/17407745211049829
Lundgren JD; Grund B; Barkauskas CE; Holland TL; Gottlieb RL; Sandkovskyc U; Brownc SM; Knowlton KU; Self WH; Files DC; Jain MK; Benfield T; Bowdishc ME; Leshnower BG; Bakerc JV; Jensen JU; Gardner EM; Ginde AA; Harris ES; Johansen IS; Markowitz N; Matthay MA; Østergaard L; Chang CC; Goodman AL; Chang W; Dewar RL; Gerry NP; Higgs ES; Highbarger H; Murray DD; Murray TA; Natarajan V; Paredes R; Parmar MKB; Phillips AN; Reilly C; Rupert AW; Sharma S; Shaw-Saliba K; Sherman BT; Teitelbaum M; Wentworth D; Cao H; Klekotka P; Babiker AG; Davey VJ; Gelijns AC; Kan VL; Polizzotto MN; Thompson BT; Lane HC; Neaton JD, 2022, 'Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels', Annals of Internal Medicine, 175, pp. 234 - 243, http://dx.doi.org/10.7326/M21-3507
Grundmann A; Hardwick M; Wu C-H; Semple M; Böhning D; Pett S; Michael B; Thomas R; Galea I, 2022, 'Prevention of neurological complications during COVID-19: a retrospective analysis of the ISARIC4C national cohort', Journal of Neurology, Neurosurgery & Psychiatry, 93, pp. e2.135 - e2.135, http://dx.doi.org/10.1136/jnnp-2022-abn2.22
Butler M; Tamborska A; Wood GK; Ellul M; Thomas RH; Galea I; Pett S; Singh B; Solomon T; Pollak TA; Michael BD; Nicholson TR, 2021, 'Considerations for causality assessment of neurological and neuropsychiatric complications of SARS-CoV-2 vaccines: From cerebral venous sinus thrombosis to functional neurological disorder', Journal of Neurology Neurosurgery and Psychiatry, 92, pp. 1144 - 1151, http://dx.doi.org/10.1136/jnnp-2021-326924
Nugent D; Stirrup O; Pett S; Panwar K; Checchi M; Mesher D; Soldan K; Beddows S; Gilson R, 2021, 'Performance of human papillomavirus DNA detection in residual specimens taken for Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid amplification testing in men who have sex with men', Sexually Transmitted Infections, 97, pp. 541 - 546, http://dx.doi.org/10.1136/sextrans-2020-054702
Ray STJ; Abdel-Mannan O; Sa M; Fuller C; Wood GK; Pysden K; Yoong M; McCullagh H; Scott D; McMahon M; Thomas N; Taylor M; Illingworth M; McCrea N; Davies V; Whitehouse W; Zuberi S; Guthrie K; Wassmer E; Shah N; Baker MR; Tiwary S; Tan HJ; Varma U; Ram D; Avula S; Enright N; Hassell J; Ross Russell AL; Kumar R; Mulholland RE; Pett S; Galea I; Thomas RH; Benjamin LA; Lim M; Hacohen Y; Solomon T; Griffiths MJ; Michael BD; Kneen R; Breen G; Castell H; Collie C; George L; Hartmann M; Henrion M; Kinali M; Petropoulos C; Ramdas S; Vlachou V; Vollmer B; Facer B; Dunai C; Benjamin L, 2021, 'Neurological manifestations of SARS-CoV-2 infection in hospitalised children and adolescents in the UK: a prospective national cohort study', Lancet Child and Adolescent Health, 5, pp. 631 - 641, http://dx.doi.org/10.1016/S2352-4642(21)00193-0
Alagaratnam J; Stöhr W; Toombs J; Heslegrave A; Zetterberg H; Gisslén M; Pett S; Nelson M; Clarke A; Nwokolo N; Johnson MA; Khan M; Hanke T; Kopycinski J; Dorrell L; Fox J; Kinloch S; Underwood J; Pace M; Frater J; Winston A; Fidler S, 2021, 'No evidence of neuronal damage as measured by neurofilament light chain in a HIV cure study utilising a kick-and-kill approach', Journal of Virus Eradication, 7, http://dx.doi.org/10.1016/j.jve.2021.100056
Burns JE; Stöhr W; Kinloch-De Loes S; Fox J; Clarke A; Nelson M; Thornhill J; Babiker A; Frater J; Pett SL; Fidler S, 2021, 'Tolerability of four-drug antiretroviral combination therapy in primary HIV-1 infection', HIV Medicine, 22, pp. 770 - 774, http://dx.doi.org/10.1111/hiv.13118
Hung R; Patel N; Fox J; Cosgrove C; Pett SL; Burns F; Ustianowski A; Rosenvinge M; Bhagani S; Dusheiko G; Childs K; Post FA, 2021, 'Prevalence of HIV/hepatitis B and HIV/hepatitis C coinfection among people of East, South, Central and West African ancestry in the United Kingdom', AIDS, 35, pp. 1701 - 1704, http://dx.doi.org/10.1097/QAD.0000000000002929
Cooke GS; Pett S; McCabe L; Jones C; Gilson R; Verma S; Ryder SD; Collier JD; Barclay ST; Ala A; Bhagani S; Nelson M; Ch'Ng C; Stone B; Wiselka M; Forton D; McPherson S; Halford R; Nguyen D; Smith D; Ansari A; Dennis E; Hudson F; Barnes EJ; Walker AS, 2021, 'Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C', Wellcome Open Research, 6, pp. 93, http://dx.doi.org/10.12688/wellcomeopenres.16594.2
Flower B; McCabe L; Le Ngoc C; Le Manh H; Le Thanh P; Dang Trong T; Vo Thi T; Vu Thi Kim H; Nguyen Tat T; Phan Thi Hong D; Nguyen Thi Chau A; Dinh Thi T; Tran Thi Tuyet N; Tarning J; Kingsley C; Kestelyn E; Pett SL; Thwaites G; Nguyen Van VC; Smith D; Barnes E; Ansari MA; Turner H; Rahman M; Walker AS; Day J; Cooke GS, 2021, 'High Cure Rates for Hepatitis C Virus Genotype 6 in Advanced Liver Fibrosis with 12 Weeks Sofosbuvir and Daclatasvir: The Vietnam SEARCH Study', Open Forum Infectious Diseases, 8, http://dx.doi.org/10.1093/ofid/ofab267
Yang H; Llano A; Cedeño S; von Delft A; Corcuera A; Gillespie GM; Knox A; Leneghan DB; Frater J; Stöhr W; Fidler S; Mothe B; Mak J; Brander C; Ternette N; Dorrell L; Sandström E; Darbyshire J; Post F; Conlon C; Anderson J; Maini M; Peto T; Sasieni P; Miller V; Weller I; Babiker A; Pett S; Pace M; Olejniczak N; Brown H; Robinson N; Kopycinski J; Hanke T; Crook A; Kaye S; McClure M; Erlwein O; Lovell A; Khan M; Gabrielle M; Bennett R; Sy A; Gregory A; Hudson F; Russell C; Wood G; Box H; Kingsley C; Topping K; Lever A; Wills M; Fun A; Bandara M; Kelly D; Collins S; Markham A; Rauchenberger M; Sowunmi Y; Shidfar S; Hague D; Nelson M; Cerrone M; Castrillo Martinez N; Barber T; Schoolmeesters A; Weaver C; Thunder O; Rowlands J; Higgs C; Fedele S; Bracchi M; Thomas L; Bourke P; Nwokolo N; Lawrenson G; Fiorino M; Lukha H; Kinloch-de Loes S; Johnson M; Nightingale A; Ngwu N; Byrne P; Cuthbertson Z; Jones M; Fernandez T; Clarke A; Fisher M; Gleig R; Trevitt V; Fitzpatrick C; Adams T; Finnerty F; Thornhill J; Lewis H; Kuldanek K; Fox J; Lwanga J; Uzu H; Lee M, 2021, 'Incoming HIV virion-derived Gag Spacer Peptide 2 (p1) is a target of effective CD8+ T cell antiviral responses', Cell Reports, 35, http://dx.doi.org/10.1016/j.celrep.2021.109103
Phillips AN; Bansi-Matharu L; Cambiano V; Ehrenkranz P; Serenata C; Venter F; Pett S; Flexner C; Jahn A; Revill P; Garnett GP, 2021, 'The potential role of long-acting injectable cabotegravir–rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysis', Lancet Global Health, 9, pp. e620 - e627, http://dx.doi.org/10.1016/S2214-109X(21)00025-5
Wendt CH; Castro-Pearson S; Proper J; Pett S; Griffin TJ; Kan V; Carbone J; Koulouris N; Reilly C; Neaton JD, 2021, 'Metabolite profiles associated with disease progression in influenza infection', Plos One, 16, http://dx.doi.org/10.1371/journal.pone.0247493
Pett SL; Spyer M; Haddow LJ; Nhema R; Benjamin LA; Najjuka G; Bilima S; Daud I; Musoro G; Kitabalwa J; Selemani G; Kandie S; Cornelius KM; Katemba C; Berkley JA; Hassan AS; Kityo C; Hakim J; Heyderman RS; Gibb DM; Walker AS, 2021, 'Benefits of enhanced infection prophylaxis at antiretroviral therapy initiation by cryptococcal antigen status', AIDS, 35, pp. 585 - 594, http://dx.doi.org/10.1097/QAD.0000000000002781
Judd A; Collins IJ; Pett S; Gibb DM, 2021, 'Labour pains: eliminating HCV in women and children', Lancet Gastroenterology and Hepatology, 6, pp. 150 - 151, http://dx.doi.org/10.1016/S2468-1253(20)30373-3
Ross Russell AL; Hardwick M; Jeyanantham A; White LM; Deb S; Burnside G; Joy HM; Smith CJ; Pollak TA; Nicholson TR; Davies NWS; Manji H; Easton A; Ray S; Zandi MS; Coles JP; Menon DK; Varatharaj A; Mccausland B; Ellul MA; Thomas N; Breen G; Keddie S; Lunn MP; Burn JPS; Quattrocchi G; Dixon L; Rice CM; Pengas G; Al-Shahi Salman R; Carson A; Joyce EM; Turner MR; Benjamin LA; Solomon T; Kneen R; Pett S; Thomas RH; Michael BD; Galea I, 2021, 'Spectrum, risk factors and outcomes of neurological and psychiatric complications of COVID-19: a UK-wide cross-sectional surveillance study', Brain Communications, 3, http://dx.doi.org/10.1093/braincomms/fcab168
Cooke GS; Pett S; McCabe L; Jones C; Gilson R; Verma S; Ryder SD; Collier JD; Barclay ST; Ala A; Bhagani S; Nelson M; Ch'Ng C; Stone B; Wiselka M; Forton D; McPherson S; Halford R; Nguyen D; Smith D; Ansari A; Dennis E; Hudson F; Barnes EJ; Walker AS, 2021, 'Strategic treatment optimization for HCV (STOPHCV1): A randomised controlled trial of ultrashort duration therapy for chronic hepatitis C', Wellcome Open Research, 6, http://dx.doi.org/10.12688/wellcomeopenres.16594.2
Russell AR; Hardwick M; Jeyanantham A; White L; Deb S; Burnside G; Joy H; Smith C; Pollak T; Nicholson T; Davies N; Manji H; Easton A; Ray S; Zandi M; Coles J; Menon D; Varatharaj A; Mccausland B; Ellul M; Thomas N; Breen G; Keddie S; Lunn M; Salman RA-S; Carson A; Joyce E; Turner M; Benjamin L; Solomon T; Kneen R; Pett S; Thomas R; Michael B; Galea I, 2021, 'Spectrum, risk factors and outcomes of neurological complications of COVID-19', Journal of the Neurological Sciences, 429, pp. 117807 - 117807, http://dx.doi.org/10.1016/j.jns.2021.117807
Cooke GS; Pett S; McCabe L; Jones C; Gilson R; Verma S; Ryder SD; Collier JD; Barclay ST; Ala A; Bhagani S; Nelson M; Ch’Ng CL; Stone B; Wiselka M; Forton D; McPherson S; Halford R; Nguyen D; Smith D; Ansari MA; Ainscough H; Dennis E; Hudson F; Barnes EJ; Walker AS, 2021, 'Variable short duration treatment versus standard treatment, with and without adjunctive ribavirin, for chronic hepatitis C: the STOP-HCV-1 non-inferiority, factorial RCT', Efficacy and Mechanism Evaluation, 8, pp. 1 - 90, http://dx.doi.org/10.3310/eme08170
Noor NM; Pett SL; Esmail H; Crook AM; Vale CL; Sydes MR; Parmar MKB, 2020, 'Adaptive platform trials using multi-arm, multi-stage protocols: getting fast answers in pandemic settings', F1000Research, 9, pp. 1109, http://dx.doi.org/10.12688/f1000research.26253.2
Beigel JH; Tomashek KM; Dodd LE; Mehta AK; Zingman BS; Kalil AC; Hohmann E; Chu HY; Luetkemeyer A; Kline S; De Castilla DL; Finberg RW; Dierberg K; Tapson V; Hsieh L; Patterson TF; Paredes R; Sweeney DA; Short WR; Touloumi G; Lye DC; Ohmagari N; Oh MD; Ruiz-Palacios GM; Benfield T; Fätkenheuer G; Kortepeter MG; Atmar RL; Creech CB; Lundgren J; Babiker AG; Pett S; Neaton JD; Burgess TH; Bonnett T; Green M; Makowski M; Osinusi A; Nayak S; Lane HC; Rouphael NG; Traenkner JJ; Cantos VD; Alaaeddine G; Grossberg R; Riska PF; Torres-Soto M; Jilg N; Wald A; Crouch PB; Jang H; Billings J; Noren B; Van Winkle JW; Riedo FX; Wang JP; Wessolossky M; Eckhardt B; Neumann HJ; Grein J; Sutterwala F; Amin AN; Javeri H; Vu T; Mateu L; Benson CA; Ali F; Tebas P; Torgersen J; Gioukari V; Ong SWX; Mikami A; Malin JJ; Koehler P; Larson L; Hewlett A; Thomsen I; Rice TW; Taiwo B; Krueger K; Cohen SH; Thompson GR; Wolfe C; Walter EB; Frank M; Young H; Falsey AR; Branche AR; Goepfert P; Erdmann N; Yang OO; Ahn J; Goodman A; Merrick B; Novak RM; Wendrow A; Arguinchona H; Arguinchona C; George SL; Tennant J, 2020, 'Remdesivir for the treatment of COVID-19 — Final report', New England Journal of Medicine, 383, pp. 1813 - 1826, http://dx.doi.org/10.1056/NEJMoa2007764
Varatharaj A; Pollak TA; Nicholson TR; Coles JP; Benjamin LA; Carson A; Thomas RH; Michael BD; Davies NW; Breen G; Zandi M; Ellul MA; Thomas N; Tenorio EL; Sultan M; Easton A; Smith C; Kneen R; Turner MR; Manji H; Solomon T; Menon DK; Pett SL; Galea I, 2020, 'Characterising neuropsychiatric disorders in patients with COVID-19 – Authors' reply', Lancet Psychiatry, 7, pp. 934 - 935, http://dx.doi.org/10.1016/S2215-0366(20)30420-X
González-Cordón A; Assoumou L; Camafort M; Domenech M; Guaraldi G; Domingo P; Rusconi S; Raffi F; Katlama C; Masia M; Bernardino JI; Saumoy M; Pozniak A; Gatell JM; Martinez E; Vandekerckhove L; Caluwé E; De Wit S; Necsoi C; Florence E; Van Frankenhuijsen M; Allavena C; Reliquet V; Boutoille D; Cavellec M; André-Garnier E; Rodallec A; Le Tourneau T; Connault J; Molina JM; Ferret S; Previlon M; Yazdanpanah Y; Landman R; Joly V; Martinez AP; Caby F; Ktorza N; Schneider L; Stephan C; Wolf T; Schüttfort G; Rockstroh J; Wasmuth JC; Schwarze-Zander C; Boesecke C; Stellbrink HJ; Hoffmann C; Sabranski M; Esser S; Jablonka R; Wiehler H; Behrens G; Stoll M; Ahrenstorf G; Nardini G; Beghetto B; D'Arminio Montforte A; Bini T; Cogliandro V; Di Pietro M; Fusco FM; Galli M; Giacomelli A; Meraviglia P; Torres B; Mateo G; Gutierrez M; Portillo J; Merino E; Reus S; Boix V; Gutiérrez F; Padilla S; Clotet B; Negredo E; Bonjoch A; Casado JL; Bañón-Escandell S; Saban J; Duque A; Podzamczer D; Acerete L; Gonzalez-Garcia J; Arribas JR; Hontañón V; Moyle G; Pagani N; Bracchi M; Vera J; Clarke A; Adams T; Richardson C; Winston A; Mora-Peris B; Mullaney S; Waters L; de Esteban N; Milinkovic A; Pett S, 2020, 'Switching from boosted PIs to dolutegravir in HIV-infected patients with high cardiovascular risk: 48 week effects on subclinical cardiovascular disease', Journal of Antimicrobial Chemotherapy, 75, pp. 3334 - 3343, http://dx.doi.org/10.1093/jac/dkaa292
Varatharaj A; Thomas N; Ellul MA; Davies NWS; Pollak TA; Tenorio EL; Sultan M; Easton A; Breen G; Zandi M; Coles JP; Manji H; Al-Shahi Salman R; Menon DK; Nicholson TR; Benjamin LA; Carson A; Smith C; Turner MR; Solomon T; Kneen R; Pett SL; Galea I; Thomas RH; Michael BD; Allen C; Archibald N; Arkell J; Arthur-Farraj P; Baker M; Ball H; Bradley-Barker V; Brown Z; Bruno S; Carey L; Carswell C; Chakrabarti A; Choulerton J; Daher M; Davies R; Di Marco Barros R; Dima S; Dunley R; Dutta D; Ellis R; Everitt A; Fady J; Fearon P; Fisniku L; Gbinigie I; Gemski A; Gillies E; Gkrania-Klotsas E; Grigg J; Hamdalla H; Hubbett J; Hunter N; Huys AC; Ihmoda I; Ispoglou S; Jha A; Joussi R; Kalladka D; Khalifeh H; Kooij S; Kumar G; Kyaw S; Li L; Littleton E; Macleod M; Macleod MJ; Madigan B; Mahadasa V; Manoharan M; Marigold R; Marks I; Matthews P; Mccormick M; Mcinnes C; Metastasio A; Milburn-McNulty P; Mitchell C; Mitchell D; Morgans C; Morris H; Morrow J; Mubarak Mohamed A; Mulvenna P; Murphy L; Namushi R; Newman E; Phillips W; Pinto A; Price DA; Proschel H; Quinn T; Ramsey D; Roffe C; Ross Russell A; Samarasekera N, 2020, 'Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study', Lancet Psychiatry, 7, pp. 875 - 882, http://dx.doi.org/10.1016/S2215-0366(20)30287-X
Ellul M; Varatharaj A; Nicholson TR; Pollak TA; Thomas N; Easton A; Zandi MS; Manji H; Solomon T; Carson A; Turner MR; Kneen R; Galea I; Pett S; Thomas RH; Michael BD, 2020, 'Defining causality in COVID-19 and neurological disorders', Journal of Neurology Neurosurgery and Psychiatry, 91, pp. 811 - 812, http://dx.doi.org/10.1136/jnnp-2020-323667
McCabe L; White IR; Chau NVV; Barnes E; Pett SL; Cooke GS; Walker AS; Day JN; Dung NT; Flower B; Hallett T; Hung LM; Kestelyn E; Khoa DB; Pett SL; Phuong LT; Rahman M; Tarning J; Turner HC; Thwaites GE; White NJ, 2020, 'The design and statistical aspects of VIETNARMS: A strategic post-licensing trial of multiple oral direct-acting antiviral hepatitis C treatment strategies in Vietnam', Trials, 21, http://dx.doi.org/10.1186/s13063-020-04350-x
Fidler S; Stöhr W; Pace M; Dorrell L; Lever A; Pett S; Kinloch-de Loes S; Fox J; Clarke A; Nelson M; Thornhill J; Khan M; Fun A; Bandara M; Kelly D; Kopycinski J; Hanke T; Yang H; Bennett R; Johnson M; Howell B; Barnard R; Wu G; Kaye S; Wills M; Babiker A; Frater J; Sandström E; Darbyshire J; Post F; Conlon C; Anderson J; Maini M; Peto T; Sasieni P; Miller V; Weller I; Olejniczak N; Brown H; Robinson N; Crook A; McClure M; Erlwein O; Lovell A; Gabrielle M; Sy A; Gregory A; Hudson F; Russell C; Wood G; Box H; Kingsley C; Topping K; Collins S; Markham A; Rauchenberger M; Sowunmi Y; Shidfar S; Hague D; Cerrone M; Castrillo Martinez N; Barber T; Schoolmeesters A; Weaver C; Thunder O; Rowlands J; Higgs C; Fedele S; Bracchi M; Thomas L; Bourke P; Nwokolo N; Lawrenson G; Fiorino M; Lukha H; Nightingale A; Ngwu N; Byrne P; Cuthbertson Z; Jones M; Fernandez T; Fisher M; Gleig R; Trevitt V; Fitzpatrick C; Adams T; Finnerty F; Lewis H; Kuldanek K; Lwanga J; Uzu H; Lee M; Merle S; O'Rourke P; Jendrulek I; ZarkoFlynn T; Taylor M; Tiraboschi JM, 2020, 'Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial', Lancet, 395, pp. 888 - 898, http://dx.doi.org/10.1016/S0140-6736(19)32990-3
Walker SM; Cox E; Revill P; Musiime V; Bwakura-Dangarembizi M; Mallewa J; Cheruiyot P; Maitland K; Ford N; Gibb DM; Walker AS; Soares M; Mugyenyi P; Kityo C; Wavamunno P; Nambi E; Ocitti P; Ndigendawani M; Kabahenda S; Kemigisa M; Acen J; Olebo D; Mpamize G; Amone A; Okweny D; Mbonye A; Nambaziira F; Rweyora A; Kangah M; Kabaswahili V; Abach J; Abongomera G; Omongin J; Aciro I; Philliam A; Arach B; Ocung E; Amone G; Miles P; Adong C; Tumsuiime C; Kidega P; Otto B; Apio F; Baleeta K; Mukuye A; Abwola M; Ssennono F; Baliruno D; Tuhirwe S; Namisi R; Kigongo F; Kikyonkyo D; Mushahara F; Tusiime J; Musiime A; Nankya A; Atwongyeire D; Sirikye S; Mula S; Noowe N; Lugemwa A; Kasozi M; Mwebe S; Atwine L; Senkindu T; Natuhurira T; Katemba C; Ninsiima E; Acaku M; Kyomuhangi J; Ankunda R; Tukwasibwe D; Ayesiga L; Hakim J; Nathoo K; Reid A; Chidziva E; Mhute T; Tinago GC; Bhiri J; Mudzingwa S; Phiri M; Steamer J; Nhema R; Warambwa C; Musoro G; Mutsai S; Nemasango B; Moyo C; Chitongo S; Rashirai K; Vhembo S; Mlambo B; Nkomani S; Ndemera B; Willard M; Berejena C; Musodza Y; Matiza P, 2020, 'The cost-effectiveness of prophylaxis strategies for individuals with advanced HIV starting treatment in Africa', Journal of the International AIDS Society, 23, http://dx.doi.org/10.1002/jia2.25469
Parmar MKB; Noor NM; Pett SL; Esmail H; Crook AM; Vale CL; Sydes MR, 2020, 'Adaptive platform trials using multi-arm, multi-stage protocols: Getting fast answers in pandemic settings', F1000research, 9, http://dx.doi.org/10.12688/f1000research.26253.1
Burns JE; Stirrup OT; Dunn D; Runcie-Unger I; Milinkovic A; Candfield S; Lukha H; Severn A; Waters L; Edwards S; Gilson R; Pett SL, 2020, 'No overall change in the rate of weight gain after switching to an integrase-inhibitor in virologically suppressed adults with HIV', AIDS, 34, pp. 109 - 114, http://dx.doi.org/10.1097/QAD.0000000000002379
Davey RT; Fernández-Cruz E; Markowitz N; Pett S; Babiker AG; Wentworth D; Khurana S; Engen N; Gordin F; Jain MK; Kan V; Polizzotto MN; Riska P; Ruxrungtham K; Temesgen Z; Lundgren J; Beigel JH; Lane HC; Neaton JD; Butts J; Denning E; DuChene A; Krum E; Harrison M; Meger S; Peterson R; Quan K; Shaughnessy M; Thompson G; Vock D; Metcalf J; Dewar R; Rehman T; Natarajan V; McConnell R; Flowers E; Smith K; Hoover M; Coyle EM; Munroe D; Aagaard B; Pearson M; Cursley A; Webb H; Hudson F; Russell C; Sy A; Purvis C; Jackson B; Collaco-Moraes Y; Carey D; Robson R; Sánchez A; Finley E; Conwell D; Losso MH; Gambardella L; Abela C; Lopez P; Alonso H; Touloumi G; Gioukari V; Anagnostou O; Avihingsanon A; Pussadee K; Ubolyam S; Omotosho B; Solórzano C; Petersen T; Vysyaraju K; Rizza SA; Whitaker JA; Nahra R; Baxter J; Coburn P; Gardner EM; Scott JA; Faber L; Pastor E; Makohon L; MacArthur RA; Hillman LM; Farrough MJ; Polenakovik HM; Clark LA; Colon RJ; Kunisaki KM; DeConcini M; Johnson SA; Wolfe CR; Mkumba L; Carbonneau JY; Morris A; Fitzpatrick ME; Kessinger CJ; Salata RA; Arters KA; Tasi CM; Panos RJ; Lach LA, 2019, 'Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial', Lancet Respiratory Medicine, 7, pp. 951 - 963, http://dx.doi.org/10.1016/S2213-2600(19)30253-X
Peterson I; Ntsui N; Jambo K; Kelly C; Huwa J; Afran L; Tatuene JK; Pett S; Romain Henrion MY; Van Oosterhout J; Heyderman RS; Mwandumba H; Benjamin LA; Angus B; Connor M; Dwivedi R; Haddow L; Heikinheimo-Connell T; Joekes E; Kandoole V; Nyrienda M; Malisita K; Mallewa J; Soliman EZ; Solomon T, 2019, 'Evaluating the reactivation of herpesviruses and inflammation as cardiovascular and cerebrovascular risk factors in antiretroviral therapy initiators in an African HIV-infected population (RHICCA): A protocol for a longitudinal cohort study', BMJ Open, 9, http://dx.doi.org/10.1136/bmjopen-2018-025576
Castillo-Mancilla JR; Phillips AN; Neaton JD; Neuhaus J; Sharma S; Baker JV; Collins S; Mannheimer S; Pett S; Touzeau-Römer V; Polizzotto MN; Lundgren JD; Gardner EM, 2019, 'Incomplete ART adherence is associated with higher inflammation in individuals who achieved virologic suppression in the START study', Journal of the International AIDS Society, 22, http://dx.doi.org/10.1002/jia2.25297
Gatell JM; Assoumou L; Moyle G; Waters L; Johnson M; Domingo P; Fox J; Martinez E; Stellbrink HJ; Guaraldi G; Masia M; Gompels M; De Wit S; Florence E; Esser S; Raffi F; Stephan C; Rockstroh J; Giacomelli A; Vera J; Bernardino JI; Winston A; Saumoy M; Gras J; Katlama C; Pozniak AL; Vandekerckhove L; Caluwé E; Necsoi C; Van Frankenhuijsen M; Allavena C; Reliquet V; Cavellec M; Rodallec A; Le Tourneau T; Connault J; Molina JM; Ferret S; Previlon M; Yazdanpanah Y; Landman R; Joly V; Martinez AP; Caby F; Ktorza N; Schneider L; Wolf T; Schüttfort G; Wasmuth JC; Schwarze-Zander C; Boesecke C; Hoffmann C; Sabranski M; Esser S; Jablonka R; Wiehler H; Behrens G; Stoll M; Ahrenstorf G; Nardini G; Beghetto B; Montforte ADA; Bini T; Cogliandro V; Di Pietro M; Fusco FM; Galli M; Rusconi S; Meraviglia P; González-Cordón A; Torres B; Mateo G; Gutierrez M; Portillo J; Merino E; Reus S; Boix V; Gutiérrez F; Padilla S; Clotet B; Negredo E; Bonjoch A; Casado JL; Bañón-Escandell S; Saban J; Duque A; Podzamczer D; Acerete L; Gonzalez-Garcia J; Arribas JR; Pagani N; Bracchi M; Clarke A; Adams T; Richardson C; Mora-Peris B; Mullaney S; De Esteban N; Milinkovic A; Pett S, 2019, 'Immediate versus deferred switching from a boosted protease inhibitor-based regimen to a dolutegravir-based regimen in virologically suppressed patients with high cardiovascular risk or age ≥50 years: Final 96-week results of the NEAT022 study', Clinical Infectious Diseases, 68, pp. 597 - 606, http://dx.doi.org/10.1093/cid/ciy505
Nguyen HA; Cooke GS; Day JN; Flower B; Phuong LT; Hung TM; Dung NT; Khoa DB; Kestelyn E; Thwaites GE; Turner HC; Chau NVV; Tarning J; McCabe L; Rahman M; Van Vinh Chau N; White NJ; Pett SL; Sarah Walker A; Hallett TB, 2019, 'The direct-medical costs associated with interferon-based treatment for Hepatitis C in Vietnam', Wellcome Open Research, 4, http://dx.doi.org/10.12688/wellcomeopenres.15408.1
Polizzotto M; Van Bockel D; Law C; Roberts J; Buckland G; Just S; Comben S; Hillman R; Gilson R; Pett S; Poynten M; Law M; Kelleher A; Emery S, 2019, '96P Clearance of HPV Anal Premalignant Lesions and Modulation of Systemic Immune Responses to HPV Oncogenes with Low Dose Pomalidomide', Annals of Oncology, 30, pp. xi35, http://dx.doi.org/10.1093/annonc/mdz451.005
Alagaratnam J; Stohr W; Toombes J; Zetterberg H; Pett S; Nelson M; Kinloch S; Clarke A; Nwokolo N; Johnson M; Fox J; Hanke T; Kopycinski J; Dorrell L; Babiker A; Frater J; Winston A; Fidler S, 2019, 'No evidence of neuroaxonal injury following latency reversal with vorinostat and HIV-1 specific vaccination in the RIVER trial', Journal of Virus Eradication, 5, pp. 22 - 23, http://dx.doi.org/10.1016/s2055-6640(20)31066-9
Kityo C; Szubert AJ; Siika A; Heyderman R; Bwakura-Dangarembizi M; Lugemwa A; Mwaringa S; Griffiths A; Nkanya I; Kabahenda S; Wachira S; Musoro G; Rajapakse C; Etyang T; Abach J; Spyer MJ; Wavamunno P; Nyondo-Mipando L; Chidziva E; Nathoo K; Klein N; Hakim J; Gibb DM; Walker AS; Pett SL, 2018, 'Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial', Plos Medicine, 15, http://dx.doi.org/10.1371/journal.pmed.1002706
Vanderven HA; Wragg K; Ana-Sosa-Batiz F; Kristensen AB; Jegaskanda S; Wheatley AK; Wentworth D; Wines BD; Hogarth PM; Rockman S; Kent SJ; Emery S; Lane HC; Amin J; Davey RT; Markowitz NP; Pett SL; Beigel J; Gardner E; Temesgen Z, 2018, 'Anti-Influenza Hyperimmune Immunoglobulin Enhances Fc-Functional Antibody Immunity During Human Influenza Infection', Journal of Infectious Diseases, 218, pp. 1383 - 1393, http://dx.doi.org/10.1093/infdis/jiy328
Simonsen L; Higgs E; Taylor RJ; Wentworth D; Cozzi-Lepri A; Pett S; Dwyer DE; Davey R; Lynfield R; Losso M; Morales K; Glesby MJ; Weckx J; Carey D; Lane C; Lundgren J; Emery S, 2018, 'Using clinical research networks to assess severity of an emerging influenza pandemic', Clinical Infectious Diseases, 67, pp. 341 - 349, http://dx.doi.org/10.1093/cid/ciy088
Mallewa J; Szubert AJ; Mugyenyi P; Chidziva E; Thomason MJ; Chepkorir P; Abongomera G; Baleeta K; Etyang A; Warambwa C; Melly B; Mudzingwa S; Kelly C; Agutu C; Wilkes H; Nkomani S; Musiime V; Lugemwa A; Pett SL; Bwakura-Dangarembizi M; Prendergast AJ; Gibb DM; Walker AS; Berkley JA; Kityo C; Wavamunno P; Nambi E; Ocitti P; Ndigendawani M; Kabahenda S; Kemigisa M; Acen J; Olebo DF; Mpamize G; Amone A; Okweny D; Mbonye A; Nambaziira F; Rweyora A; Kangah M; Kabaswahili B; Abach J; Omongin J; Aciro I; Philliam A; Arach B; Ocung E; Amone G; Miles P; Adong C; Tumsuiime C; Kidega P; Otto B; Apio F; Mukuye A; Abwola M; Ssennono F; Baliruno D; Tuhirwe S; Namisi R; Kigongo F; Kikyonkyo D; Mushahara F; Tusiime J; Musiime A; Nankya A; Atwongyeire D; Sirikye S; Myalo S; Noowe N; Kasozi M; Mwebe S; Atwine L; Senkindu T; Natuhurira I; Katemba C; Ninsiima E; Acaku M; Kyomuhangi J; Ankunda R; Tukwasibwe D; Ayesiga L; Hakim J; Nathoo K; Reid A; Mhute T; Tinago G; Bhiri J; Phiri M; Steamer J; Nhema R; Musoro G; Mutsai S; Nemasango B; Moyo C; Chitongo S; Rashirai K; Vhembo S; Mlambo B; Ndemera B, 2018, 'Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial', Lancet HIV, 5, pp. e231 - e240, http://dx.doi.org/10.1016/S2352-3018(18)30038-9
Back to profile page